Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty

COMFORTAGE

COMFORTAGE is a joint effort of medical experts (i.e., neurologists, psychiatrists, neuropsychologists, nurses, memory clinics), social scientists and humanists, technical experts (i.e., data scientists, AI experts, robotic experts) and Digital Innovation Hubs to establish a pan European framework for Community-based, Integrated and People-Centric...

Funding Programme
Start Date
End Date
Total Funding
€ 17 591 490

Prevention and Remediation of Insulin Multimorbidity in Europe

PRIME

PRIME introduces the novel concept of insulin signalling as a key mechanism underlying the multimorbidity of major mental and somatic illnesses. It is well known that aberrant insulin signalling causes high health and socioeconomic burden through its role in diabetes, metabolic syndrome, and obesity. We posit that the impact of ‘insulinopathies’ is...

Funding Programme
Start Date
End Date
Total Funding
€ 6 000 001
European Countries Involved

PROMOTING MENTAL WELLBEING IN THE AGEING URBAN POPULATION: DETERMINANTS, POLICIES AND INTERVENTIONS IN EUROPEAN CITIES

MINDMAP

Major depressive disorder, dementia, anxiety disorders, and substance abuse affect a substantial part of the European older population. Over 70% of Europeans reside in cities, and this percentage will increase in the next decades. Urbanization and ageing have enormous implications for public mental health. Cities pose major challenges for older...

Funding Programme
Start Date
End Date
Total Funding
€ 5 743 160
European Countries Involved

Promotion of plasticity as a treatment for neurodegenerative conditions

PLASTICISE

Neurodegenerative diseases all cause damage to the circuitry of the nervous system, with loss of connections, axons and neurons. The loss can be gradual, as in Alzheimer’s disease, rapid as in stroke, or intermediate as in the delayed neuronal loss after stroke. Following damage, the nervous system is able partially to compensate through the...

Funding Programme
Start Date
End Date
Total Funding
€ 6 767 728
European Countries Involved

Psychiatric Ratings using Intermediate Stratified Markers

PRISM

The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. However, without a biological rationale for these disorders, drug development has dramatically stagnated in the past decades. In a coordinated effort encompassing academic experts, SMEs, patient and family...

Funding Programme
Start Date
End Date
Total Funding
€ 16 195 875
European Countries Involved

Psychosocial fActors Relevant to BrAin DISorders in Europe

PARADISE

The overall prevalence of brain disorders – both neurological and psychiatric – is very high in Europe. Although it is well known that the burden and costs of these disorders are high, there is evidence that the overall, personal, social and economic costs of brain disorders have been underestimated because of the lack of valid and reliable...

Funding Programme
Start Date
End Date
Total Funding
€ 1 675 934
European Countries Involved

Quantum-enhanced nonlinear imaging

QuNIm

Many pioneering advances in medicine and biology require observation of the microscopic world with high resolution and without damaging the specimen. One of the most widespread techniques is multiphoton fluorescence microscopy, which allows full 3D imaging via optical sectioning, i.e., imaging of planes within the sample without the need for...

Funding Programme
Start Date
End Date
Total Funding
€ 1 979 704
European Countries Involved

REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENT

AD-RIDDLE

Alzheimer's disease (AD), the main cause of dementia, is one of the major global health challenges of our time. This disabling disorder affects 55 million people worldwide, with costs above $1.3 trillion. With 67 million people at risk for AD dementia (prodromal and preclinical AD) in Europe alone, it is a major unmet public health need, with...

Funding Programme
Start Date
End Date
Total Funding
€ 12 090 250

Research empowerment on solute carriers

ReSOLUTE

Transport proteins are the gate-keepers of our cells, effectively controlling the flow of nutrients and other molecules across the cell membrane. With over 400 members, solute carriers represent the largest class of transport proteins. Yet although they have been implicated in diseases ranging from Alzheimer’s disease and amyotrophic lateral...

Funding Programme
Start Date
End Date
Total Funding
€ 23 850 000
European Countries Involved

Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia

RECOGNISED

In recent years there is mounting evidence that type 2 diabetes (T2D) is associated with cognitive impairment and dementia, which can be considered as a “new” long-term diabetic co-morbid complication with dramatic consequences for patients and their families and a significant impact for healthcare systems. At present there are no reported...

Funding Programme
Start Date
End Date
Total Funding
€ 5 998 273

Risk and Modifying factors in Fronto Temporal Dementia

RiMod-FTD

Fronto-Temporal-Dementia (FTD) is a devastating progressive early onset dementia with a strong genetic influence. Currently, seven genes have been identified that explain >50% of familial cases, but how these different genes lead to a very similar clinical phenotype is still an unanswered question. Currently, there is no cure for FTD and for the...

Funding Programme
Start Date
End Date
Total Funding
€ 3 190 796
European Countries Involved

Robotic Assistant for MCI patients at home

RAMCIP

RAMCIP will research and develop a novel domestic service robot, with the aim to proactively and discreetly assist older persons, MCI and AD patients in their every day life. Instead of simply being an obedient servant, the RAMCIP robot will have high-level cognitive functions, driven through advanced human activity and home environment modelling...

Funding Programme
Start Date
End Date
Total Funding
€ 3 981 178
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).